BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chao J, Bledsoe G, Chao L. Kallikrein-kinin in stem cell therapy. World J Stem Cells 2014; 6(4): 448-457 [PMID: 25258666 DOI: 10.4252/wjsc.v6.i4.448]
URL: https://www.wjgnet.com/1948-0210/full/v6/i4/448.htm
Number Citing Articles
1
Miruna Mihaela Micheu, Alina Ioana Scarlatescu, Alexandru Scafa-Udriste, Maria Dorobantu. The Winding Road of Cardiac Regeneration—Stem Cell Omics in the SpotlightCells 2018; 7(12): 255 doi: 10.3390/cells7120255
2
Micheli M. Pillat, Mona N. Oliveira, Helena Motaln, Barbara Breznik, Talita Glaser, Tamara T. Lah, Henning Ulrich. Glioblastoma‐mesenchymal stem cell communication modulates expression patterns of kinin receptors: Possible involvement of bradykinin in information flowCytometry Part A 2016; 89(4): 365 doi: 10.1002/cyto.a.22800
3
Wenjuan Liu, Robert C. Stanton, Zhaoyun Zhang. The kallikrein–kinin system in diabetic kidney diseaseCurrent Opinion in Nephrology and Hypertension 2017; 26(5): 351 doi: 10.1097/MNH.0000000000000344
4
Rajko Igić. Four decades of ocular renin-angiotensin and kallikrein-kinin systems (1977–2017)Experimental Eye Research 2018; 166: 74 doi: 10.1016/j.exer.2017.05.007
5
Michelle Alexander-Curtis, Rick Pauls, Julie Chao, John J Volpi, Philip M Bath, Todd A. Verdoorn. Human tissue kallikrein in the treatment of acute ischemic strokeTherapeutic Advances in Neurological Disorders 2019; 12: 175628641882191 doi: 10.1177/1756286418821918
6
Sooram Banesh, Surajbhan Sevda. Reference Module in Biomedical Sciences2024;  doi: 10.1016/B978-0-323-99967-0.00234-9
7
Marina Devetzi, Maria Goulielmaki, Nicolas Khoury, Demetrios Spandidos, Georgia Sotiropoulou, Ioannis Christodoulou, Vassilis Zoumpourlis. Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review)International Journal of Molecular Medicine 2018;  doi: 10.3892/ijmm.2018.3361